GlassScriptPhysician profile
Kashif S Bhutto
NPI 1083791651
$19,466.56
in general payments reported to CMS, 2019-2025
51 companies · $6,346 in 2025
The $6,346 reported for 2025 was more than what 90% of Pulmonary Disease providers received nationally (typical 2025 total: $500).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $2,272 · 2020: $1,480 · 2021: $1,893 · 2022: $2,480 · 2023: $2,359 · 2024: $2,636 · 2025: $6,346.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $5,564 · Education: $4,080 · Travel and Lodging: $1,697.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $5,564.13 |
| Education | $4,079.94 |
| Travel and Lodging | $1,696.75 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Intuitive Surgical, INC. | $5,389.31 | 2025 | |
| Astrazeneca Pharmaceuticals LP | $2,607.82 | 2019-2025 | Breztri, Fasenra, Airsupra |
| Glaxosmithkline, LLC. | $2,068.20 | 2019-2025 | Trelegy Ellipta, Arexvy, Nucala |
| Boehringer Ingelheim Pharmaceuticals, INC. | $1,498.78 | 2019-2024 | Spiriva Respimat, Ofev, Stiolto Respimat |
| Olympus Corporation of The Americas | $983.18 | 2022-2025 | |
| Insmed, INC. | $936.43 | 2019-2025 | Arikayce |
| Genzyme Corporation | $731.93 | 2019-2025 | |
| Regeneron Healthcare Solutions, INC. | $592.41 | 2023-2025 | Dupixent |
| Grifols USA, LLC | $436.78 | 2019-2024 | Prolastin-C Liquid |
| Takeda Pharmaceuticals U.S.A., INC. | $420.34 | 2020-2024 | Glassia |
| Electromed, INC. | $375.00 | 2019-2025 | Smartvest |
| Merck Sharp & Dohme LLC | $278.80 | 2019-2025 | Zerbaxa, Recarbrio, Dificid |
| Axsome Therapeutics, INC. | $229.66 | 2023-2025 | Sunosi |
| Mylan Specialty L.P. | $211.64 | 2019-2024 | Yupelri |
| Mallinckrodt Hospital Products INC. | $202.04 | 2021-2022 |
Show all 51 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Sunovion Pharmaceuticals INC. | $197.04 | 2019-2020 | |
| Genentech USA, INC. | $190.25 | 2019-2020 | |
| Resmed Corp | $151.42 | 2019-2024 | |
| Shionogi INC | $148.46 | 2023-2025 | Fetroja |
| Baxter Healthcare | $134.89 | 2022-2025 | Hillrom - Vest System Model 105 Home Care, Hillrom - Life 2000 Ventilation System |
| Shire North American Group INC | $133.06 | 2019 | |
| Pfizer INC. | $125.03 | 2019-2024 | |
| Sanofi-Aventis U.S. LLC | $122.13 | 2019-2022 | |
| United Therapeutics Corporation | $117.93 | 2019-2025 | Tyvaso, Tyvaso |
| Harmony Biosciences LLC | $103.67 | 2022-2024 | |
| Actelion Pharmaceuticals US, INC. | $97.99 | 2020-2024 | Opsumit |
| Philips North America LLC | $96.24 | 2019-2023 | |
| Ethicon INC. | $92.72 | 2022 | |
| Janssen Pharmaceuticals, INC | $92.64 | 2019-2022 | |
| Eisai INC. | $86.82 | 2020-2021 | |
| Circassia INC. | $83.26 | 2019-2020 | |
| Verona Pharma, INC. | $61.16 | 2025 | Ohtuvayre |
| Vanda Pharmaceuticals INC. | $57.99 | 2020 | |
| Advanced Respiratory, INC | $48.92 | 2019 | |
| La Jolla Pharmaceutical Company | $42.26 | 2024-2025 | Giapreza |
| Jazz Pharmaceuticals INC. | $37.58 | 2024 | |
| Veran Medical Technologies, INC. | $27.78 | 2019 | |
| Pinnacle Biologics, INC | $25.03 | 2024 | Photofrin |
| Amgen INC. | $21.61 | 2023 | Tezspire |
| Monaghan Medical Corporation | $21.16 | 2024 | Aerobika |
| Optinose US, INC. | $20.69 | 2024 | |
| Idorsia Pharmaceuticals US INC | $20.55 | 2022 | |
| Vifor Pharma, INC. | $20.43 | 2024 | Zemaira |
| Melinta Therapeutics, LLC | $20.31 | 2023 | Vabomere |
| Teva Pharmaceuticals USA, INC. | $17.73 | 2022 | |
| Avadel Cns Pharmaceuticals, LLC | $16.66 | 2025 | Lumryz |
| Pulmonx Corporation | $16.10 | 2023 | Pulmonx Chartis Tablet Console, Zephyr Delivery Catheter, Zephyr Endobronchial Valve |
| Fisher & Paykel Healthcare INC | $15.99 | 2021 | |
| Allergan, INC. | $13.77 | 2019 | |
| Itamar Medical INC | $13.36 | 2022 | |
| Cumberland Pharmaceuticals, INC. | $11.61 | 2020 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Kashif Bhutto listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.